Alethio Therapeutics Limited
Research and experimental development on biotechnology · Abingdon
ActiveUnited KingdomIncorporated 2021Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
−£2,063,617
Cash
—
Turnover
—
Profit / loss
—
Current assets
£2,893,957
Creditors < 1 year
£5,253,164
Equity
−£2,063,617
Average employees
11
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-12-31Company | 2024-12-31Company | 2023-12-31Company | 2022-12-31 | 2021-07-12 |
|---|---|---|---|---|---|
| Balance sheet | |||||
| Net assets | −£2,063,617 | £592,569 | £2,514,001 | — | — |
| Equity | −£2,063,617 | £592,569 | £2,514,001 | £1,709,175 | — |
| Assets | |||||
| Fixed assets | £295,590 | £82,005 | £85,392 | £6,843 | — |
| Property, plant & equipment | — | — | — | — | £0 |
| Current assets | £2,893,957 | £5,758,894 | £3,008,633 | £1,977,015 | — |
| Liabilities | |||||
| Creditors within one year | £5,253,164 | £748,330 | — | £274,683 | — |
| Net current assets | −£2,359,207 | £5,010,564 | £2,428,609 | £1,702,332 | — |
| Assets less current liabilities | −£2,063,617 | £5,092,569 | £2,514,001 | £1,709,175 | — |
| People & pay | |||||
| Average employees | 11 | 7 | 7 | -3 | — |
| Source evidence | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
2 outstanding chargesFixed · created 2023-11-08
—
OutstandingFixed · created 2023-11-08
—
OutstandingShow 3 satisfied / released
Fixed · created 2023-03-15 · satisfied 2023-12-05
—
SatisfiedFixed · created 2023-01-05 · satisfied 2023-12-05
—
SatisfiedFixed · created 2021-12-30 · satisfied 2023-03-10
—
Satisfied